Purpose: Male urinary incontinence is thought to be infrequent. We sought to describe the prevalence of urinary incontinence in a male treatment seeking cohort enrolled in the LURN (Symptoms of Lower Urinary Tract Dysfunction Research Network). Materials and Methods: Study inclusion and exclusion criteria, including men with prostate cancer or neurogenic bladder, were previously reported. LURN participants prospectively completed questionnaires regarding lower urinary tract symptoms and other clinical variables. Men were grouped based on incontinence type, including 1) no urinary incontinence, 2) post-void dribbling only and 3) urinary incontinence. Comparisons were made using ANOVA and multivariable regression. Results: Of the 477 men 24% reported no urinary incontinence, 44% reported post-void dribbling only and 32% reported urinary incontinence. African American men and those with sleep apnea were more likely to be in the urinary incontinence group than in the no urinary incontinence group (OR 3.2, p ¼ 0.02 and OR 2.73, p ¼ 0.003, respectively). Urinary incontinence was associated with significantly higher bother compared to men without leakage (p <0.001).
URINARY incontinence is a common complaint that is thought to be significantly more prevalent in the female population with an estimated prevalence of up to 55%. UI can be categorized as UUI, SUI and mixed UI, in which SUI and UUI are present. The ICS (International Continence Society) has defined post-void (or post-micturition) dribbling/post-void UI as a separate symptom associated with the phenomenon of involuntary urine loss immediately after a person has finished passing urine. 1 Urinary leakage is extremely bothersome, usually associated with anxiety and depression, causes decreased QOL and is a significant economic burden. 2e5 However, because UI can be embarrassing and there is a perception that it is a normal and untreatable part of aging, not everyone with UI seeks treatment. This may be particularly relevant to the male population, in which UI is historically thought to be infrequent.
In men the prevalence of UI and PVD is largely unknown. Most previous studies evaluating the UI prevalence have been done in women. Few studies in men have distinguished among different types of UI. Prior series of community dwelling men, including the NHANES (National Health and Nutrition Examination Survey), the BACH (Boston Area Community Health) Survey, the EPIC (Expanded Prostate Cancer Index Composite) and the EpiLUTS, reported a prevalence of UI in men ranging from 5.3% to 45.8%. 6 Among men with UI in these cohorts 1.2% to 48.6% had UUI, 0.8% to 12.5% had SUI, 1.0% to 15.4% had mixed UI and 2.9% to 59% other types of UI, including PVD. 6 Subsequent evaluation of the BACH cohort revealed that 8.7% of the men reported PVD. 7 In the EPIC 16.9% of the men reported post-micturition symptoms while in the EpiLUTS PVD was noted in 93.0% of the other incontinence group. 8 To our knowledge the frequency of UI is unknown among men who actively seek treatment. The prevalence and types of UI in care seeking men may differ from that in community based men and a characterization of care seeking men would be extremely relevant for care. We sought to assess the prevalence and characteristics of care seeking men with and without UI and its subtypes, and examine relationships with medical comorbidities (eg diabetes, sleep apnea, bowel symptoms, sexual functioning, anxiety, depression and stress).
METHODS Study Design and Population
The goal of the LURN is to phenotype men and women with LUTS to develop improved clinical tools and treatments. Men and women in the LURN Observational Cohort Study 9 were recruited from tertiary referral centers between January 2015 and January 2017. However, only male participants were included in the current analysis. 10 Briefly, all consenting participants were adults (18 years old or older) who presented to a LURN physician as new or existing patients with at least 1 urinary symptom identified based on the LUTS Tool.
11 Study exclusion criteria were previously reported. 10 Men with prostate cancer, including those with low risk disease, were excluded to remove potential confounding of LUTS by a pelvic malignancy. Data collection at the baseline visit included a standard clinical examination, medical history, and patient reported urinary symptoms, pelvic floor symptoms, psychological symptoms and QOL.
Measures
The LUTS Tool, version 1.0 (Pfizer, New York, New York) is a 44-item questionnaire assessing the frequency and bother of LUTS. 11 Seven questions on incontinence and a single question on terminal dribble were used to categorize men into the UI, PVD only and nonUI groups. The 7 questions were Question 16, a to g, including "How often in the past week have you (a) leaked urine just after you have finished urinating? (b) leaked urine in connection with a sudden need to rush to urinate? (c) leaked urine in connection with laughing, sneezing or coughing? (d) leaked urine in connection with physical activities, such as exercising or lifting heavy objects? (e) leaked urine while you are sleeping? (f) leaked urine during sexual activity? and (g) leaked urine for no reason?" The single question was Question 5, "During the past week, how often have you had a trickle or dribble at the end of your urine flow?"
Responses of rarely or never on all 8 questions were classified as nonUI. Responses of sometimes or greater on questions about terminal dribble or leak after voiding without indications of other incontinence symptoms were classified as PVD only. Responses of sometimes or greater on at least 1 other symptom of incontinence were classified as UI.
In addition to the LUTS Tool, 11 participants completed the AUA SI, 12 the PROMIS measures of constipation, diarrhea, bowel incontinence, depression and anxiety, 13 the IIEF, 14 the PSS (Perceived Stress Scale) 15 and the Childhood Traumatic Events Scale. 16 PROMIS 13 measures were administered via short forms scored as T-scores normalized to a reference population (mean AE SD 50 AE 10 by definition) except for bowel incontinence, for which there were not enough items to convert to the T-score metric. The Childhood Traumatic Events Scale 16 was collapsed into a summary measure indicating whether the participant had experienced any trauma.
Statistical Methods
Complete responses to the 8 questions needed for UI grouping were required for study inclusion. Demographic and clinical data were missing in fewer than 1% of cases. Questionnaire data were missing in 3% to 8% of the cohort except for the AUA SI, which was missing in 12%. A given measure was analyzed only in participants in whom the measure could be scored according to validated guidelines.
Demographic and clinical characteristics of the LURN male cohort are shown using the mean AE SD for continuous variables, and the frequency and percent for categorical variables. Tests of group differences were performed with the chi-square test, nonparametric ANOVA and the Kruskal-Wallis test. Similar descriptive statistics and statistical tests were calculated for each physical and psychological measure. The PROMIS measures are presented as continuous measures and the percent of severe symptoms, defined as greater than 1 SD above the population mean (ie T-scores greater than 60).
Multivariable multinomial models were fitted. Candidate covariates included age, race, body mass index, education, employment status, smoking status, diabetes, sleep apnea, the FCI (Functional Comorbidity Index) 17 and the LURN site. Multivariable linear regression was applied to explore adjusted associations among measures of fecal incontinence, sexual function and psychological health using the same set of predictors. Model selection was guided by the method of best subsets 18 and final model determination incorporated clinical expertise and judgment. All p values were adjusted for multiple comparisons using the false discovery rate correction. 19 Analyses were completed with SASÒ, version 9.4.
RESULTS
Of the 519 men enrolled in the LURN Observational Cohort Study 9 477 were included in the current analysis. Mean age was 60.9 AE 13.3 years. Of the cohort 80% were Caucasian, most were educated, including 60% with a bachelor degree or higher, and 38% were employed full-time while 49% were not employed or not looking for work (supplementary  table 1 , http://jurology.com/). Of the subjects 46% reported being current or former smokers, 26% had been diagnosed with sleep apnea and 18% had diabetes. The average FCI 17 was 2.1 AE 1.8. UI was reported in 51% of the men. PVD and UUI were most common, occurring in 41% and 29% of the men, respectively (see figure) . SUI was less common at 3% to 4% of the cohort. PVD and UUI were most bothersome with 39% and 35% of subjects, respectively, reporting that they were at least somewhat bothered (see figure) .
Categorization into incontinence subgroups revealed that 116 men (24%) had no UI or PVD, 211 (44%) had PVD only and 150 (32%) had UI. Compared with the other groups the PVD only group was younger (mean age 57.9 AE 14.1 years, p ¼ 0.001) while the UI group was more likely to have comorbidities, such as obesity in 48% (p ¼ 0.02), diabetes in 27% (p ¼ 0.01) and obstructive sleep apnea in 36% (p ¼ 0.01).
Of the African American participants 50% were in the UI group compared with 29% of Caucasian participants and 35% of participants of another race (p ¼ 0.07). The UI group was more likely to report urinary urgency and leakage due to urgency at rates of 86% and 87%, respectively (supplementary table 2, http://jurology.com/). The PROMIS constipation and diarrhea scores were close to population means in all groups, although they were higher in the UI group than in the nonUI and PVD only groups (p ¼ 0.02 and 0.03, respectively). Elevated scores on the constipation scale were more common in the UI group than in the PVD only and nonUI groups (13% vs 7% and 4%, respectively, p ¼ 0.07).
Sexual function was impaired in the cohort on average with the mean score of 15.5 AE 11.3 in the moderate dysfunction range. Erectile function was worse in the UI group at a mean score of 12.6 with 65% of men reporting moderate or severe dysfunction, that is IIEF less than 17 (p <0.01).
The average PROMIS depression and anxiety scores were close to the normative population mean of 50. Fewer than 10% of participants overall reported elevated depression or anxiety scores, defined as T-scores greater than 60 (1 SD above population mean scores). Elevated depression and anxiety were more common in the UI group with 15% and 17% of subjects, respectively, reporting scores above 60 compared with 3% to 6% in the PVD only and nonUI groups (p 0.001). PSS scores were also higher in the UI group, including mean scores of 13.0 for UI, 10.7 for PVD only and 8.4 for nonUI (p <0.001).
Significant predictors of urinary symptom group membership included age, race, sleep apnea and clinical site (see table) . The odds of being in the PVD Distribution of responses to LUTS Tool questions related to UI and PVD 11 only group compared with the nonUI group were 3% lower per each year increase in age (OR 0.97, 95% CI 0.95e0.99). However, African American participants showed threefold higher odds of being in the UI group than in the nonUI group (OR 3.20, 95% CI 1.35e7.62). The diagnosis of sleep apnea also increased the odds of being in the UI group compared with the nonUI group (OR 2.73, 95% CI 1.51e4.95).
After adjustment for the listed factors all significant differences among the urinary symptom groups remained statistically significant except differences in IIEF (supplementary table 2, http://jurology.com/). Supplementary table 3 (http://jurology.com/) shows full model results. For all other measures the differences between the UI and nonUI groups were significant but the PVD only and nonUI groups showed no significant difference. Average estimated scores in the UI group compared with the nonUI groups were 0.75 units higher for bowel incontinence, 2.41 units higher for the diarrhea scale and 3.00 units higher for the constipation scale. Depression scores were 4.80 units higher in the UI group and anxiety scores were higher by a similar magnitude.
DISCUSSION
Half of the men with LUTS who sought care at tertiary referral urology clinics reported some form of urinary leakage. The most commonly reported forms were UUI and PVD. Compared to prior community dwelling male studies 6, 20, 21 we noted a significantly higher prevalence of UI among men who seek clinical care for LUTS (supplementary figure, http://jurology.com/).
A likely explanation of the increased frequency of UI in our study relates to patient care seeking behaviors. The EpiLUTS data suggest that only a relatively small proportion of patients actively seek care for LUTS, ranging from 5.6% to 29.1% based on the LUTS symptom. 8 However, the LURN only included patients who presumably were bothered enough to seek care, which is supported by the high level of bother reported in the current study (see figure) . In addition, previous studies done in the LURN demonstrated a relationship of symptom bother and severity with treatment seeking behaviors. 22 The association between race and UI is supported by several studies, 20, 23 including the OAB-POLL (OAB [overactive bladder] on Physical and Occupational Limitations). 24 The latter study demonstrated that African American men had a significantly higher prevalence of UUI than other racial groups (10% vs 6%). The current results also highlight other self-reported comorbidities that have been previously associated with UI, including sleep apnea. While sleep disturbance was historically thought to contribute only to nocturia, several recent studies have suggested that it is also associated with many daytime LUTS. 25, 26 Secondary analyses of the Epi-LUTS data demonstrated that patients with sleep apnea were 1.6 times more likely to experience UI than men without sleep apnea. 11 Although to our knowledge the mechanisms that link UI and sleep apnea are unknown, this potentially opens an opportunity for a nonpharmacological therapy of UI (eg pressure airway systems).
Urological physiology and gastrointestinal function physiology are known to be interrelated. Crosstalk between neural pathways in the pelvic organs is necessary for the routine mediation of bladder, bowel and sexual function. 27, 28 This crosstalk also provides a pathway for abnormal function of these organs with the potential for dysfunction of a pelvic organ leading to functional changes in another organ system. The results of this study support this theory of an increasing frequency of bowel dysfunction, specifically constipation, in men with UI.
The associations between UI groups and measures of psychosocial health likely reflect the large psychological impact of urinary leakage. However, no causal relationships could be determined in this observational study. The EpiLUTS also demonstrated a high frequency of anxiety and depression among men with UI. 3 These findings were consistent with other studies showing higher anxiety and depression rates among patients with UI.
29,30
To our knowledge the direction of the relationship(s) between UI and mental health are as yet unknown and may be bidirectional. Additional research is warranted to further define these relationships and potentially exploit novel opportunities for intervention.
We identified a relationship between increased LUTS and PVD compared to men without UI. This supports previous findings that PVD is more prevalent in men with voiding and storage symptoms. 7 Other comorbidities, including bowel dysfunction, anxiety and perceived stress, were also increased in this group compared with the nonUI group (supplementary table 2, http://jurology.com/). While to our knowledge the exact etiology of PVD remains unknown, these factors may provide insight into PVD pathophysiology. Further studies aimed at pinpointing the mechanisms underlying PVD are required.
The results of this study should be evaluated in the context of its limitations. The prevalence of UI may have been underestimated since many patients with SUI were excluded from analysis due to a history of prostate cancer. We present self-reported symptoms using the LUTS Tool. 11 However, the patients who reported these symptoms did not present with a chief complaint of all of these symptoms and so it is possible that incontinence was not the primary reason for seeking care. Therefore, the presence of UI may ultimately not be the most clinically significant symptom that motivated the visit.
Many patients in this study had previously undergone medical or surgical intervention for LUTS before presenting to tertiary referral centers. Thus, the impact of these previous interventions on UI remains to be determined.
Also, comparison between the LURN cohort and other previous study cohorts may be limited by the questionnaires that were administered. The treatment seeking cohort in the LURN is distinct from community populations in that the urinary symptoms that drive men to seek care may be unique and especially bothersome.
CONCLUSIONS
UI is a common symptom among men who present to urology clinics. This is particularly concerning because the recommended and most commonly used questionnaire to assess male LUTS in the United States is the I-PSS (International Prostate Symptom Score)/AUA SI. 12 This questionnaire does not assess for UI or PVD and, therefore, it may be associated with a false-negative impression that urinary leakage is not present in or problematic for patients. UI and PVD are bothersome for all patients and associated with significantly decreased health related QOL. 3, 4, 7 This report provides a substantial rationale for a new or updated symptom questionnaire that provides a more comprehensive assessment. Capturing UI and PVD information, and assessing the presence of other related comorbidities (eg sleep apnea, diabetes, increased body mass index and anxiety) will have the potential to significantly improve current clinical practices and treatments in men who present with LUTS. Based on these associations clinicians should consider screening men with these comorbidities for incontinence and LUTS. 
EDITORIAL COMMENT
Helfand et al present data on urinary incontinence on 477 men taking part in the LURN study. Postvoid dribbling occurred in 41% of the men with 29% reporting urge urinary incontinence. Overall 51% of subjects reported urinary incontinence. Erectile dysfunction, depression and anxiety scores were also associated with urinary incontinence. Significant predictors of urinary incontinence were age, race, sleep apnea and clinical site. This important study demonstrates a higher than expected incidence of male incontinence. This cohort of males who sought treatment at tertiary care centers provided answers to 6 questionnaires but the presenting complaint was not recorded.
